ACM
LLY icon

Alethea Capital Management’s Eli Lilly LLY Stock Holding History

Alethea Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-383
Closed -$299K – 44
2025
Q2 		$299K Buy
+383
New +$298K 0.23% 23
2017
Q4 		– Sell
-9,449
Closed -$808K – 97
2017
Q3 		$808K Buy
+9,449
New +$775K 0.95% 29
2016
Q1 		– Sell
-4,878
Closed -$411K – 76
2015
Q4 		$411K Buy
+4,878
New +$405K 0.48% 52

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Alethea Capital Management's LLY Position: Q3 2025 in Review

Alethea Capital Management sold out of Eli Lilly (LLY) in Q3 2025, closing a stake of 383 shares — an estimated $299K sold.

Alethea Capital Management first reported a position in LLY in Q4 2015 and held it in 3 quarters. The position peaked at $808K in Q3 2017. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Alethea Capital Management reported no remaining Eli Lilly position as of Q3 2025 after selling out during the quarter.
  • Alethea Capital Management sold 383 Eli Lilly shares in Q3 2025, an estimated $299K.
  • Alethea Capital Management first reported a position in Eli Lilly in Q4 2015 and held it in 3 quarters.
  • Alethea Capital Management's Eli Lilly position peaked at $808K in Q3 2017.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Alethea Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.